Enanta Pharmaceuticals Inc (ENTA)
16.15
-0.30
(-1.82%)
USD |
NASDAQ |
Apr 15, 16:00
16.17
+0.02
(+0.12%)
After-Hours: 20:00
Enanta Pharmaceuticals Total Liabilities (Quarterly): 236.62M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 236.62M |
| September 30, 2023 | 245.54M |
| June 30, 2023 | 257.35M |
| March 31, 2023 | 57.07M |
| December 31, 2022 | 46.70M |
| September 30, 2022 | 54.08M |
| June 30, 2022 | 47.19M |
| March 31, 2022 | 48.24M |
| December 31, 2021 | 56.21M |
| September 30, 2021 | 39.36M |
| June 30, 2021 | 32.59M |
| March 31, 2021 | 31.74M |
| December 31, 2020 | 29.02M |
| September 30, 2020 | 30.55M |
| June 30, 2020 | 31.15M |
| March 31, 2020 | 27.51M |
| December 31, 2019 | 28.69M |
| September 30, 2019 | 27.34M |
| June 30, 2019 | 25.39M |
| March 31, 2019 | 25.37M |
| December 31, 2018 | 27.38M |
| September 30, 2018 | 20.55M |
| June 30, 2018 | 18.18M |
| March 31, 2018 | 21.25M |
| Date | Value |
|---|---|
| December 31, 2017 | 23.14M |
| September 30, 2017 | 24.96M |
| June 30, 2017 | 14.97M |
| March 31, 2017 | 12.95M |
| December 31, 2016 | 10.21M |
| September 30, 2016 | 11.34M |
| June 30, 2016 | 12.93M |
| March 31, 2016 | 15.18M |
| December 31, 2015 | 14.10M |
| September 30, 2015 | 9.856M |
| June 30, 2015 | 9.492M |
| March 31, 2015 | 21.67M |
| December 31, 2014 | 21.71M |
| September 30, 2014 | 6.761M |
| June 30, 2014 | 6.561M |
| March 31, 2014 | 6.631M |
| December 31, 2013 | 4.578M |
| September 30, 2013 | 6.505M |
| June 30, 2013 | 5.26M |
| March 31, 2013 | 7.252M |
| December 31, 2012 | 6.265M |
| September 30, 2012 | 8.233M |
| June 30, 2012 | 164.58M |
| September 30, 2011 | 4.142M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.39M
Minimum
Jun 2019
257.35M
Maximum
Jun 2023
71.17M
Average
39.36M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 235.21M |
| Galectin Therapeutics Inc | 88.44M |
| Viking Therapeutics Inc | 20.07M |
| Akero Therapeutics Inc | 44.96M |
| 89bio Inc | 59.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 428.50M |
| Shareholders Equity (Quarterly) | 191.88M |
| Current Ratio | 6.254 |